Consortium

Our ambition is to increase our knowledge of the pathophysiology of hepatocellular carcinoma in obesity. HepatoSCRIPT combines scientists and clinicians with expertise in cancer, immunology, metabolism, liver biology and beyond state-of-the-art technologies.